Concepedia

Author

Shi Chang

The University of Texas MD Anderson Cancer Center

Also Known As

S M Chang, S. M. Chang, Shi Chang

22

Publications

1.1K

Citations

7

H-Index

27

Concepts

All Affiliations

The University of Texas MD Anderson Cancer CenterThe University of Texas Health Science Center at San AntonioDana-Farber Cancer InstituteDana-Farber Brigham Cancer CenterNorthwestern University
SC

About

Shi Chang is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, oncology, and radiation oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

6

6

1K

2

Neurology

3

3

169

3

Cell Biology

2

2

755

4

Health Sciences

1

1

89

5

Pathology

1

1

739

Shi Chang

×

7

Publications

1.1K

Citations

7

H-Index

YearCitations

Androgen-independent cancer progression and bone metastasis in the LNCaP model of human prostate cancer.

George N. Thalmann, Ploutarchos Anezinis, Shi Chang,

PubMed

1994

739

Phase I/II study of sorafenib in combination with temsirolimus for recurrent glioblastoma or gliosarcoma: North American Brain Tumor Consortium study 05-02

E. Q. Lee, John G. Kuhn, Kathleen R. Lamborn,

Neuro-Oncology

2012

110

Phase III randomized study of postradiotherapy chemotherapy with alpha-difluoromethylornithine-procarbazine, N-(2-chloroethyl)-N'-cyclohexyl-N-nitrosurea, vincristine (DFMO-PCV) versus PCV for glioblastoma multiforme.

Victor A. Levin, Joon H. Uhm, Kurt A. Jaeckle,

PubMed

2000

89

A phase I trial of erlotinib in patients with nonprogressive glioblastoma multiforme postradiation therapy, and recurrent malignant gliomas and meningiomas

Jeffrey J. Raizer, L. E. Abrey, Andrew B. Lassman,

Neuro-Oncology

2009

53

Phase I study of erlotinib and CCI-779 (temsirolimus) for patients with recurrent malignant gliomas (MG) (NABTC 04–02)

H. I. Robins, Patrick Y. Wen, Shi Chang,

Journal of Clinical Oncology

2007

42

Phase I/II study of erlotinib and temsirolimus for patients with recurrent malignant gliomas (MG) (NABTC 04–02)

Shi Chang, John G. Kuhn, Kathleen R. Lamborn,

Journal of Clinical Oncology

2009

17

Prostatic carcinogenesis evoked by cellular interaction.

Leland W.K. Chung, Shi Chang, Carol Bell,

Environmental Health Perspectives

1988

16

Page 1